Print

Print


The source of this article is the August 2005 of Arch Neurol:
http://tinyurl.com/bvbfw

Management of Referred Deep Brain Stimulation Failures
A Retrospective Analysis From 2 Movement Disorders Centers

Michael S. Okun, MD; Michele Tagliati, MD; Michael Pourfar, MD; Hubert H.
Fernandez, MD; Ramon L. Rodriguez, MD; Ronald L. Alterman, MD; Kelly D.
Foote, MD


Arch Neurol. 2005;62:(doi:10.1001/archneur.62.8.noc40425).

ABSTRACT

Background  Since the Food and Drug Administration approved DBS, there has
been a surge in the number of centers providing the procedure. There is
currently no consensus regarding appropriate screening procedures,
necessary training of individuals providing the therapy, the need for an
interdisciplinary team, or guidelines for the management of complications.
An increasing number of patients come to experienced DBS centers after
unsatisfactory results from DBS surgery. An attempt is made herein to
evaluate the reasons for DBS failure in a series of such patients and to
make recommendations to improve overall DBS outcomes.

Objective  To improve outcomes of deep brain stimulation (DBS) surgery by
analyzing a series of patients who had suboptimal results from DBS.

Methods  Forty-one consecutive patients complaining of suboptimal results
from DBS surgery came to the University of Florida Movement Disorders
Center, or to Beth Israel Movement Disorders Center, over a 24-month
period. All patients had undergone implantation of DBS devices at outside
medical centers. Each patient was evaluated by a movement disorders
neurologist, and the complete medical record was reviewed. The DBS device
for each patient was interrogated for adverse effects and programmed for
maximal benefit. Postoperative imaging studies were evaluated whenever
possible.

Results  The average age of patients was 63.4 years (range, 49-84 years).
The indication for surgery (by record review) included 9 patients with
essential tremor, 31 with Parkinson disease, and 1 with dystonia. The
diagnoses after referral examination included 5 with essential tremor, 26
with Parkinson disease, 3 with Parkinson disease and dementia, 1 with
Parkinson disease and essential tremor, 1 with corticobasal degeneration, 1
with dystonia, 2 with multiple system atrophy, 1 with progressive
supranuclear palsy, and 1 with myoclonus. Issues related to inadequate
preoperative screening: Thirty (73%) of 41 patients saw a movement
disorders specialist prior to DBS implantation. Fourteen (34%) patients had
neuropsychological testing, 4 (10%) did not have testing, and in 23 cases
(56%), it could not be determined whether or not they were tested. Five
(12%) of 41 patients had an inadequate medication trial, and 5 patients
(12%) had significant cognitive dysfunction prior to their DBS
implantation. Surgical and device-related complications: Nineteen (46%) of
41 patients had suboptimally placed electrodes. Seven electrodes (17%) were
replaced with improvement. Three patients' devices had failed due to end of
battery life, 2 had infections, and 1 had a fractured lead. Programming and
medication adjustments: Seven (17%) of 41 patients had no or poor access to
programming. Two patients (5%) moved, and 2 physicians (5%) moved, creating
issues with access to care. Eight patients (20%) required local follow-up
(they flew to remote centers to have the surgery performed). Fifteen
patients (37%) were inadequately programmed and improved significantly with
reprogramming. Six patients (15%) experienced partial improvement with
reprogramming, and 21 patients (51%) failed to improve despite extensive
reprogramming. Thirty patients (73%) benefited from medication changes, 4
(10%) had antidepressants added to their regimens, and 1 (2%) had donepezil
hydrochloride added. One patient's carbidopa/levodopa (2%) was restarted
after complete discontinuation. Outcomes: With the various postoperative
interventions described, 21 (51%) of 41 patients had good outcomes, 6 (15%)
had modest clinical improvement, and 14 (34%) did not improve.

Conclusions  With appropriate intervention, 51% of patients who complained
of "failed" DBS procedures ultimately had good outcomes. Thirty-four
percent of these patients had persistently poor outcomes despite maximal
intervention. This case series provides important insights into reasons for
"DBS failure" and proposes strategies to manage patients with DBS more
effectively.

Published online June 13, 2005 (doi:10.1001/archneur.62.8.noc40425).

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn